EuroClonality logo

EuroClonality Educational Workshops

Clonality testing is at present an established tool in the diagnosis of malignant lymphomas. Between 5-15% of samples that are submitted to pathology laboratories and are suspected to be malignant lymphomas can benefit from clonality testing, provided that this is performed by laboratories with sufficient expertise. With the introduction of a new and complete set of primer sets for the full program of clonality testing by the EuroClonality/BIOMED-2 Consortium in 2003, a major step in standardization and quality improvement was set. At the moment many laboratories throughout the world have introduced this technology, resulting in questions on pitfalls in technique and the interpretation of the results.

EuroClonality/BIOMED-2 Educational Workshops

The EuroClonality/BIOMED-2 Consortium decided to organize annual workshops on "Clonality Assessment in Pathology" as a service for laboratories that have introduced clonality testing using the EuroClonality/BIOMED-2 primers sets in order to address these questions and to further improve the quality and reliability of the technique in routine practice. Since the vision of EuroClonality is that clonality testing can only be performed reliably when there is close interaction between the clinical molecular biologist and the hematopathologist and/or immunologists (or flow cytometry experts), these workshops are organized for such partners and are based on interprofessional learning.


Dr. Patricia Groenen

Clinical Scientist in Molecular Pathology

Radboudumc (Nijmegen, NL)

Prof. Dr. Falko Fend


University Hospital Tuebingen (Tuebingen, DE)

Prof. Dr. Anton Langerak

Laboratory specialist medical biology

Erasmus MC (Rotterdam, NL)


Prof. Dr. Han van Krieken


Radboudumc (Nijmegen, NL)

(workshops 2006 - 2016)